A Study of the Safety and Efficacy of Patients With Familial Hypercholesterolaemia Taking Colesevelam as add-on Therapy to Their Existing Medication

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

October 31, 2009

Conditions
Familial Hypercholesterolemia
Interventions
DRUG

Colesevelam hydrochloride film-coated tablets

tablets

DRUG

Placebo

Tablets

Trial Locations (8)

Unknown

Service d'Endocrinologie, Metabolisme Prevention des Maladies Cardio-Vasculaires, Paris

Kardiologie, Marburg

Academic Medical Centre, Amsterdam

University Medical Centre, Nijmegen

University Medical Centre, Utrecht

TweeSteden Ziekenhius, Waalwijk

Centre for Metabolism and Endocrinology, Huddinge

Department of Medicine, University of Manchester, Manchester

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00655265 - A Study of the Safety and Efficacy of Patients With Familial Hypercholesterolaemia Taking Colesevelam as add-on Therapy to Their Existing Medication | Biotech Hunter | Biotech Hunter